Rekom Biotech

Rekom Biotech is a privately-held, revenue-generating company operating as a specialized supplier and service provider within the global in vitro diagnostics (IVD) market. Its core business is the production of key raw materials like recombinant antigens and antibodies, which are essential components for diagnostic test kits used in human and veterinary infectious diseases. The company leverages a flexible manufacturing platform, primarily using E. coli expression systems, and has recently gained recognition and public funding for its R&D projects, indicating growth and technological validation.

Design and manufacturing of IVD reagents, specializing in chimeric multi-epitope recombinant antigens produced in E. coli and polyclonal antibodies produced in rabbits. Platform enables development of high-sensitivity/specificity diagnostic components.

Rekom competes in a fragmented but crowded market with large, diversified life science tools companies (e.g., Thermo Fisher, Merck) and many niche reagent manufacturers. Its competitive edge lies in its focus on customization, proprietary chimeric antigen design, and agility as a specialized player, though it lacks the scale and brand recognition of the industry giants.